Prof. Armin Gerger provides a review of the BEACON Study.
Since 2012 Dr Armin Gerger is professor at the Medial University in Graz, Austria. He works as a clinical oncologist and coordinates the Subcentre for Gastrointestinal Neoplasia at the Comprehensive Cancer Centre, Graz. He leads the Pharmacogenetics Research Unit, at the Division of Clinical Oncology of the Medical University of Graz, and the Area “Cancer” of the Centre for Biomarker Research in Medicine (CBmed). Dr Gerger’s research focuses on prognostic and predictive genetic biomarkers in gastrointestinal cancer, which he developed further as a research fellow at the Norris Comprehensive Cancer Centre of the University of Southern California. Dr Gerger’s research activity is mirrored in several papers in high-ranked scientific journals and significant extramural funding.
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Share this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre.
Meet the experts
Other programmes of interest
Animated Video
Oncology
Precision oncology in prostate and gastric cancer: tips for optimal genomic testing
From sample collection through to diagnostic modalities
Experts
Dr Alexander Wyatt, Prof. Frédéric BibeauEndorsed by
-
Downloadable
Resources -
4 MIN
-
Dec 2024
Podcast
Episode
2
of 2
Oncology
HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch
Medical experts discuss how to approach sequencing in clinical practice
Experts
Prof. Arndt Vogel, Dr Lorenza Rimassa, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
26 MIN
-
Dec 2024
Podcast
Oncology
Testing to treatment of BRAF-mutant metastatic NSCLC
Medical experts share their insights on testing and treatment
Experts
Prof. David Planchard, Dr Federico Cappuzzo-
Downloadable
Resources -
23 MIN
-
Nov 2024
Podcast
Episode
1
of 2
Oncology
HCC podcast series part 1: The use of IO in unresectable HCC
Medical experts discuss safety and efficacy of IO and IO combinations, clinical trial data, and best practice
Experts
Dr Rachna Shroff, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
23 MIN
-
Nov 2024
Video
Oncology
The emerging role of artificial intelligence in precision oncology
Expert opinion on the clinical application of artificial intelligence (AI)
Experts
Prof. Albrecht Stenzinger-
Downloadable
Resources -
6 MIN
-
Nov 2024
Podcast
Oncology
BRAF-mutated CRC: from testing to treatment
Medical experts share insights and review key clinical trials
Experts
Prof. Sebastian Stintzing, Dr Thomas WinderEndorsed by
-
Downloadable
Resources -
25 MIN
-
Nov 2024
